The term “drug price” means different things to different people.
To recap, the list price of a drug, known as the list price, isn’t what most people actually pay. This figure is a starting point for negotiations between drug companies, insurers, and pharmacy benefit managers (PBMs). The final price, impacting patients’ out-of-pocket (OOP) costs, is determined by one’s specific health insurance plan and its negotiations with these entities.
Here’s where things get interesting: While it may feel like a new, expensive drug is causing your insurance premiums to rise, it’s important to remember that the percentage of your premium dedicated to covering drug costs (around 10%) has likely remained fairly constant over the past 15 years. What has changed is the specific drugs being covered. Advancements in drug development mean there are new, potentially life-saving treatments available, but these often come with a higher price tag.
This complex system also leads to a situation where the same drug can have several different costs depending on a patient’s insurance coverage. Five people with different plans could all be prescribed the same medication, yet pay vastly different amounts at the pharmacy.
This pricing structure is a result of negotiations and rebates that happen behind the scenes, and it’s not something scientists typically delve into.